Blood test could revolutionize colorectal cancer screening
NCT ID NCT05577143
First seen Jan 05, 2026 · Last updated May 10, 2026 · Updated 19 times
Summary
This study is looking at whether two substances in the blood, called TFPI-1 and TFPI-2, can help tell apart people who have colorectal cancer from those who don't. About 303 adults aged 50 to 75 will take part. If these blood markers work well, it could lead to a simpler, less invasive way to screen for colorectal cancer in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER, COLORECTAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital HURIEZ - Chirurgie digestive et transplantation
RECRUITINGLille, France
Contact
Conditions
Explore the condition pages connected to this study.